Zurich Cantonal Bank’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
11,107
+3,262
| +42% | +$174K | ﹤0.01% | 1556 |
|
|
2025
Q1 | $318K | Hold |
7,845
| – | – | ﹤0.01% | 1861 |
|
|
2024
Q4 | $218K | Hold |
7,845
| – | – | ﹤0.01% | 2117 |
|
|
2024
Q3 | $225K | Hold |
7,845
| – | – | ﹤0.01% | 2041 |
|
|
2024
Q2 | $184K | Sell |
7,845
-1
| -0% | -$23 | ﹤0.01% | 2081 |
|
|
2024
Q1 | $198K | Sell |
7,846
-251
| -3% | -$6.34K | ﹤0.01% | 2054 |
|
|
2023
Q4 | $189K | Sell |
8,097
-1,781
| -18% | -$41.6K | ﹤0.01% | 2112 |
|
|
2023
Q3 | $500K | Buy |
9,878
+2,090
| +27% | +$106K | ﹤0.01% | 1409 |
|
|
2023
Q2 | $364K | Buy |
7,788
+1,920
| +33% | +$89.6K | ﹤0.01% | 1546 |
|
|
2023
Q1 | $225K | Sell |
5,868
-668
| -10% | -$25.6K | ﹤0.01% | 1797 |
|
|
2022
Q4 | $358K | Buy |
6,536
+2,852
| +77% | +$156K | ﹤0.01% | 1448 |
|
|
2022
Q3 | $125K | Hold |
3,684
| – | – | ﹤0.01% | 2049 |
|
|
2022
Q2 | $35K | Sell |
3,684
-151
| -4% | -$1.44K | ﹤0.01% | 2687 |
|
|
2022
Q1 | $54K | Buy |
3,835
+1,476
| +63% | +$20.8K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $50K | Hold |
2,359
| – | – | ﹤0.01% | 2734 |
|
|
2021
Q3 | $53K | Hold |
2,359
| – | – | ﹤0.01% | 2593 |
|
|
2021
Q2 | $59K | Hold |
2,359
| – | – | ﹤0.01% | 2414 |
|
|
2021
Q1 | $68K | Hold |
2,359
| – | – | ﹤0.01% | 2303 |
|
|
2020
Q4 | $61K | Hold |
2,359
| – | – | ﹤0.01% | 2377 |
|
|
2020
Q3 | $73K | Buy |
+2,359
| New | +$73K | ﹤0.01% | 2118 |
|